RA
BIOX icon

Royce & Associates’s Bioceres Crop Solutions BIOX Stock Holding History

Royce & Associates’s Portfolio BIOX Stock Details BIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-229,147
Closed -$1.8M – 840
2024
Q3 		$1.8M Sell
229,147
-19,500
-8% -$197K 0.02% 640
2024
Q2 		$2.79M Sell
248,647
-39,223
-14% -$458K 0.03% 580
2024
Q1 		$3.64M Buy
287,870
+72,870
+34% +$960K 0.03% 554
2023
Q4 		$2.95M Buy
215,000
+50,000
+30% +$585K 0.03% 593
2023
Q3 		$1.86M Sell
165,000
-15,000
-8% -$180K 0.02% 650
2023
Q2 		$2.4M Buy
180,000
+47,000
+35% +$551K 0.02% 639
2023
Q1 		$1.54M Hold
133,000
– – 0.02% 707
2022
Q4 		$1.6M Buy
133,000
+20,000
+18% +$260K 0.02% 680
2022
Q3 		$1.47M Buy
113,000
+45,000
+66% +$552K 0.02% 671
2022
Q2 		$932K Buy
+68,000
New +$902K 0.01% 757
2020
Q4 		– Sell
-50,000
Closed -$268K – 1002
2020
Q3 		$268K Hold
50,000
– – ﹤0.01% 910
2020
Q2 		$303K Hold
50,000
– – ﹤0.01% 902
2020
Q1 		$245K Buy
+50,000
New +$259K ﹤0.01% 900

Other funds holding BIOX

SP
Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return
FSC
Fourth Sail Capital Camana Bay Grand Cayman, Cayman Islands $608M AUM 48.69% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BAM
Ballast Asset Management Dallas, Texas $225M AUM 38.45% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royce & Associates's BIOX Position: Q4 2024 in Review

Royce & Associates sold out of Bioceres Crop Solutions (BIOX) in Q4 2024, closing a stake of 229,147 shares — an estimated $1.8M sold.

Royce & Associates first reported a position in BIOX in Q1 2020 and held it in 13 quarters. The position peaked at $3.64M in Q1 2024. 43 funds tracked by Wall St. Rank hold BIOX as of Q4 2024.

  • Royce & Associates reported no remaining Bioceres Crop Solutions position as of Q4 2024 after selling out during the quarter.
  • Royce & Associates sold 229,147 Bioceres Crop Solutions shares in Q4 2024, an estimated $1.8M.
  • Royce & Associates first reported a position in Bioceres Crop Solutions in Q1 2020 and held it in 13 quarters.
  • Royce & Associates's Bioceres Crop Solutions position peaked at $3.64M in Q1 2024.
  • 43 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q4 2024.

Based on Royce & Associates's 13F filing for Q4 2024, filed 10 Feb 2025.